December 16 (SeeNews) - Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said on Thursday its net profit rose to 2.27 million marka ($1.3 million/1.2 million euro) in the first nine months of 2021 from just 102,544 marka in the same period of last year, as financial revenue more than trebled.